CRMD · CorMedix Inc.
$7.54
-0.60 (-7.37%)
At close · Aug 14
Market Cap
$587.70M
Shares
77.94M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$75,000,000
as of 2026-02-02
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| — | — | — | $22,100,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-13 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 | $6,392,000 Δ | 10-Q, filed 2026-08-13 |
| 2026-03-31 | $11,092,000 | 10-Q, filed 2026-05-14 |
| 2025-06-30 | $0 Δ | 10-Q, filed 2026-08-13 |
| 2025-03-31 | $0 | 10-Q, filed 2026-05-14 |
Key facts
CIK
1410098
CUSIP
21900C308
13F (30d)
184 filings
182 filers
Visit website
Investor relations